Logo image of SEV

SONO GROUP NV (SEV) Stock Fundamental Analysis

NASDAQ:SEV - Nasdaq - NL0015000N74 - Common Stock - Currency: USD

0.207  -0.02 (-8.33%)

After market: 0.2 -0.01 (-3.38%)

Fundamental Rating

2

SEV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 83 industry peers in the Automobile Components industry. The financial health of SEV is average, but there are quite some concerns on its profitability. SEV has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

SEV had negative earnings in the past year.
SEV Yearly Net Income VS EBIT VS OCF VS FCFSEV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 -20M -40M -60M

1.2 Ratios

SEV has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
SEV Yearly ROA, ROE, ROICSEV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 0 200 400 600 800 1K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for SEV so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
SEV Yearly Profit, Operating, Gross MarginsSEV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 -100K -200K -300K

4

2. Health

2.1 Basic Checks

SEV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, SEV has more shares outstanding
Compared to 1 year ago, SEV has an improved debt to assets ratio.
SEV Yearly Shares OutstandingSEV Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 20M 40M 60M
SEV Yearly Total Debt VS Total AssetsSEV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 50M 100M

2.2 Solvency

Based on the Altman-Z score of -5.13, we must say that SEV is in the distress zone and has some risk of bankruptcy.
SEV has a Altman-Z score of -5.13. This is amonst the worse of the industry: SEV underperforms 95.24% of its industry peers.
SEV has a Debt/Equity ratio of 0.24. This is a healthy value indicating a solid balance between debt and equity.
SEV has a better Debt to Equity ratio (0.24) than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Altman-Z -5.13
ROIC/WACCN/A
WACC6.5%
SEV Yearly LT Debt VS Equity VS FCFSEV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 0 20M -20M 40M -40M 60M 80M

2.3 Liquidity

SEV has a Current Ratio of 2.93. This indicates that SEV is financially healthy and has no problem in meeting its short term obligations.
SEV has a Current ratio of 2.93. This is in the better half of the industry: SEV outperforms 66.67% of its industry peers.
SEV has a Quick Ratio of 2.93. This indicates that SEV is financially healthy and has no problem in meeting its short term obligations.
Looking at the Quick ratio, with a value of 2.93, SEV belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.93
Quick Ratio 2.93
SEV Yearly Current Assets VS Current LiabilitesSEV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 50M 100M

3

3. Growth

3.1 Past

The earnings per share for SEV have decreased strongly by -31.76% in the last year.
EPS 1Y (TTM)-31.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

Based on estimates for the next years, SEV will show a small growth in Earnings Per Share. The EPS will grow by 3.33% on average per year.
SEV is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 745.34% yearly.
EPS Next Y4.23%
EPS Next 2Y34.27%
EPS Next 3Y8.62%
EPS Next 5Y3.33%
Revenue Next Year9900%
Revenue Next 2Y1691.95%
Revenue Next 3Y2072.21%
Revenue Next 5Y745.34%

3.3 Evolution

SEV Yearly Revenue VS EstimatesSEV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2B 4B 6B 8B
SEV Yearly EPS VS EstimatesSEV Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

0

4. Valuation

4.1 Price/Earnings Ratio

SEV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year SEV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
SEV Price Earnings VS Forward Price EarningsSEV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
SEV Per share dataSEV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.27%
EPS Next 3Y8.62%

0

5. Dividend

5.1 Amount

No dividends for SEV!.
Industry RankSector Rank
Dividend Yield N/A

SONO GROUP NV

NASDAQ:SEV (7/20/2023, 8:20:59 PM)

After market: 0.2 -0.01 (-3.38%)

0.207

-0.02 (-8.33%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)06-21 2023-06-21/amc
Earnings (Next)N/A N/A
Inst Owners39.89%
Inst Owner ChangeN/A
Ins Owners0.6%
Ins Owner Change0%
Market Cap18.19M
Analysts77.14
Price Target2.69 (1199.52%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-66.87%
Min EPS beat(2)-80.62%
Max EPS beat(2)-53.11%
EPS beat(4)0
Avg EPS beat(4)-49.12%
Min EPS beat(4)-80.62%
Max EPS beat(4)-13.62%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-77.1%
Min Revenue beat(2)-81.01%
Max Revenue beat(2)-73.19%
Revenue beat(4)0
Avg Revenue beat(4)-82.51%
Min Revenue beat(4)-91.68%
Max Revenue beat(4)-73.19%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)32.99%
EPS NQ rev (1m)-29.82%
EPS NQ rev (3m)-24.72%
EPS NY rev (1m)49.44%
EPS NY rev (3m)49.44%
Revenue NQ rev (1m)37.79%
Revenue NQ rev (3m)40.93%
Revenue NY rev (1m)167.91%
Revenue NY rev (3m)167.91%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 76.48
P/FCF N/A
P/OCF N/A
P/B 0.57
P/tB 0.58
EV/EBITDA N/A
EPS(TTM)-2.92
EYN/A
EPS(NY)-0.16
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS0
BVpS0.36
TBVpS0.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.24
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.93
Quick Ratio 2.93
Altman-Z -5.13
F-ScoreN/A
WACC6.5%
ROIC/WACCN/A
Cap/Depr(3y)269.07%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-31.76%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%N/A
EPS Next Y4.23%
EPS Next 2Y34.27%
EPS Next 3Y8.62%
EPS Next 5Y3.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next Year9900%
Revenue Next 2Y1691.95%
Revenue Next 3Y2072.21%
Revenue Next 5Y745.34%
EBIT growth 1Y-9.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-105.52%
EBIT Next 3Y15.2%
EBIT Next 5Y37%
FCF growth 1Y-3873.37%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-3874.79%
OCF growth 3YN/A
OCF growth 5YN/A